These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 3583396)

  • 1. Carcinogenicity of alkylating cytostatic drugs: conclusions and directions for future research.
    Kaldor J; Schmähl D
    IARC Sci Publ; 1986; (78):321-3. PubMed ID: 3583396
    [No Abstract]   [Full Text] [Related]  

  • 2. Carcinogenicity of alkylating cytostatic drugs in animals.
    Berger MR
    IARC Sci Publ; 1986; (78):161-76. PubMed ID: 3583389
    [No Abstract]   [Full Text] [Related]  

  • 3. Treosulphan.
    IARC Monogr Eval Carcinog Risk Chem Hum; 1981 May; 26():341-7. PubMed ID: 6944265
    [No Abstract]   [Full Text] [Related]  

  • 4. [Pulmonary complications caused by cytostatic drugs].
    Bruntsch U
    MMW Munch Med Wochenschr; 1980 Sep; 122(37):1260-1. PubMed ID: 6158682
    [No Abstract]   [Full Text] [Related]  

  • 5. Experimental investigations with anti-cancer drugs for carcinogenicity with special reference to immunedepression.
    Schmähl D
    Recent Results Cancer Res; 1975; (52):18-28. PubMed ID: 1234999
    [No Abstract]   [Full Text] [Related]  

  • 6. [Secondary tumors following cytostatic chemotherapy with alkylating agents in man; the toxicological viewpoints].
    Schmähl D; Petru E
    Dtsch Med Wochenschr; 1986 May; 111(21):833-5. PubMed ID: 3698866
    [No Abstract]   [Full Text] [Related]  

  • 7. Test for carcinogenicity of food additives and chemotherapeutic agents by the pulmonary tumor response in strain A mice.
    Stoner GD; Shimkin MB; Kniazeff AJ; Weisburger JH; Weisburger EK; Gori GB
    Cancer Res; 1973 Dec; 33(12):3069-85. PubMed ID: 4202501
    [No Abstract]   [Full Text] [Related]  

  • 8. Sister chromatid exchanges induced by cancer chemotherapeutic agents in vitro and in vivo: consideration of the hazard of drugs as possible mutagens and carcinogens causing second malignancies.
    Abe T; Tsuda S; Maekawa T; Taniwaki M; Sonoda Y; Ide T; Misawa S; Takino T; Inoue K
    Cancer Treat Rep; 1985 May; 69(5):505-14. PubMed ID: 4005873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carcinogenicity of alkylating cytostatic drugs. Proceedings of a symposium. Heidelberg, Federal Republic of Germany, 25-27 November 1985.
    IARC Sci Publ; 1986; (78):1-338. PubMed ID: 3583383
    [No Abstract]   [Full Text] [Related]  

  • 10. Alkylation of DNA and its aftermath.
    Lawley PD
    Bioessays; 1995 Jun; 17(6):561-8. PubMed ID: 7575500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Carcinogenesis and teratogenesis. Comparative studies from the viewpoint of teratology].
    von Kreybig T
    Arzneimittelforschung; 1970 May; 20(5):591-601. PubMed ID: 4918294
    [No Abstract]   [Full Text] [Related]  

  • 12. Alkylating agents.
    Connors TA
    Cancer Chemother Biol Response Modif; 1992; 13():31-44. PubMed ID: 1389913
    [No Abstract]   [Full Text] [Related]  

  • 13. [A comparison of the destructive effects of five antitumour agents on various normal tissues in mice].
    Cheng YS; Li HT; Yang J
    Yao Xue Xue Bao; 1965 Sep; 12(9):606-14. PubMed ID: 5899044
    [No Abstract]   [Full Text] [Related]  

  • 14. Quantitative comparisons between carcinogenicity, mutagenicity and electrophilicity of direct-acting N-nitroso compounds and other alkylating agents.
    Bartsch H; Malaveille C; Tomatis L; Brun G; Dodet B; Terracini B
    IARC Sci Publ; 1982; (41):525-32. PubMed ID: 6754595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carcinogenicity of alkylating agents.
    Weisburger EK
    Public Health Rep (1896); 1966 Sep; 81(9):772-6. PubMed ID: 4957936
    [No Abstract]   [Full Text] [Related]  

  • 16. Carcinogenicity of epoxides, lactones, and peroxy compounds. II.
    Van Duuren BL; Orris L; Nelson N
    J Natl Cancer Inst; 1965 Oct; 35(4):707-17. PubMed ID: 5841060
    [No Abstract]   [Full Text] [Related]  

  • 17. Developing guidelines for working with antineoplastic drugs.
    Harrison BR
    Am J Hosp Pharm; 1981 Nov; 38(11):1686-93. PubMed ID: 7304620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alkylating agents: in vitro studies of cross-resistance patterns in human cell lines.
    Teicher BA; Cucchi CA; Lee JB; Flatow JL; Rosowsky A; Frei E
    Cancer Res; 1986 Sep; 46(9):4379-83. PubMed ID: 3731096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug resistance in cancer.
    Curt GA; Clendeninn NJ; Chabner BA
    Cancer Treat Rep; 1984 Jan; 68(1):87-99. PubMed ID: 6198082
    [No Abstract]   [Full Text] [Related]  

  • 20. [Experimental studies on the carcinogenic effects of anticancer chemotherapeutics and immunosuppressive agents].
    Schmähl D; Osswald H
    Arzneimittelforschung; 1970 Oct; 20(10):1461-7. PubMed ID: 5536412
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.